Surprise Question in End of Life (SeQuEL) Care and the Effect of Prompting Palliative Care Consultation: End-Stage Liver Disease
NCT06400498 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97
Last updated 2025-08-19
Summary
This is a single center randomized platform trial determining whether prompting consideration of palliative care consultation through the electronic health record impacts the number of palliative consultations placed and hospital-free days among hospitalized adults with End-Stage Liver Disease.
Conditions
- End-Stage Liver Disease
Interventions
- BEHAVIORAL
-
Prompted Palliative Care Consult
When a patient is randomized to the Palliative Care Consultation Prompt Group, a clinical decision support tool in the electronic health record will inform the treating clinician of the patient's serious illness and the results of the Surprise Question and prompt the treating clinician to consider a palliative care consultation. If the treating clinician feels a palliative care consultation would be indicated for the patient, the clinical decision support tool will facilitate the placement of a palliative care consultation by the treating clinician. If the treating clinician feels that a palliative care consultation would not be indicated, then the clinical decision support will record a reason it is not indicated.
Sponsors & Collaborators
-
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Mohana Karlekar, MD · Vanderbilt University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-05
- Primary Completion
- 2025-05-05
- Completion
- 2025-08-05
Countries
- United States
Study Locations
More Related Trials
-
LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver Disease
NCT04953143 ·Status: COMPLETED ·Phase: NA
-
Hospital @ Home Model of Care for Cirrhosis
NCT06396897 ·Status: RECRUITING ·Phase: NA
-
CAREGIVER: A Trial to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis
NCT04205396 ·Status: COMPLETED ·Phase: NA
-
Health IT Generated PROs to Improve Outcomes in Cirrhosis
NCT03564626 ·Status: COMPLETED ·Phase: NA
-
Nurse Assisted Post-discharge Intervention in Decompensated Cirrhosis
NCT04158986 ·Status: COMPLETED ·Phase: NA
-
Care Algorithm and Clinic Decision System on Hepatic Rehabilitation in Patients With Liver Cirrhosis
NCT06995196 ·Status: COMPLETED ·Phase: NA
-
Description of the Evolution of Plasma and Urinary Concentrations of Iohexol in a Cirrhotic Patient Population
NCT03769597 ·Status: COMPLETED ·Phase: PHASE4
-
Study of microRNAs in a Decompensated Cirrhosis
NCT03905746 ·Status: RECRUITING
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
NCT05205954 ·Status: RECRUITING ·Phase: NA
-
Difference in Patterns of Liver Diseases Related Admissions After the Era of DAAS
NCT05284916 ·Status: UNKNOWN
-
Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial
NCT06263816 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function
NCT04128462 ·Status: WITHDRAWN ·Phase: PHASE3
-
Vienna Vascular Liver Disease Study
NCT03541057 ·Status: RECRUITING
-
Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites
NCT01188746 ·Status: COMPLETED ·Phase: NA
-
Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis
NCT01214226 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035 ·Status: RECRUITING
-
Patients' Outcome With Severe or Fulminant Hepatic Insufficiency, Hospitalized in the Public Hospitals of Paris
NCT04658407 ·Status: UNKNOWN
-
An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension
NCT01640964 ·Status: COMPLETED ·Phase: PHASE2
-
Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy
NCT02401490 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of the Effect of Two Interventions on Liver Frailty Index in Pre-frail and Frail Cirrhotic Patients Enlisted for Liver Transplantation
NCT06149026 ·Status: RECRUITING ·Phase: NA
-
Safety and Tolerance on Lipids of Parenteral and Enteral Nutrition in Critically Ill Patients With Liver Failure
NCT00522730 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis
NCT00570622 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD
NCT02612428 ·Status: TERMINATED ·Phase: PHASE3
-
EUS-guided PSE in Combination With EUS-guided Treatment of Varices for Patients With Portal Hypertension
NCT04692805 ·Status: UNKNOWN ·Phase: NA
-
Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC
NCT02338297 ·Status: UNKNOWN ·Phase: PHASE3